- Home
- CVM vs AIFA Comparison
CVM vs AIFA Comparison
Compare CVM & AIFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVM | AIFA |
|---|---|---|
| Founded | 1983 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.6M | 27.2M |
| IPO Year | 1996 | 2017 |
Fundamental Metrics
Financial Performance| Metric | CVM | AIFA |
|---|---|---|
| Price | $1.79 | $3.74 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $12.50 | N/A |
| AVG Volume (30 Days) | 265.5K | ★ 381.3K |
| Earning Date | 11-05-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $264,033.00 | ★ $7,655,039.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 65.45 | 20.50 |
| 52 Week Low | $0.89 | $1.52 |
| 52 Week High | $9.35 | $8.93 |
Technical Indicators
Market Signals| Indicator | CVM | AIFA |
|---|---|---|
| Relative Strength Index (RSI) | 49.17 | 43.56 |
| Support Level | $1.01 | $2.80 |
| Resistance Level | $2.83 | $8.93 |
| Average True Range (ATR) | 0.27 | 0.76 |
| MACD | -0.06 | -0.25 |
| Stochastic Oscillator | 12.82 | 2.06 |
Price Performance
Historical ComparisonAbout CVM Cel-Sci Corporation
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.
About AIFA All In FutureTech Alliance Inc. Common Stock
All In FutureTech Alliance Inc operates an AI-focused digital infrastructure platform. Its activities include opportunities in AI infrastructure, silicon photonics-enabled computing, fiber-optic network transmission, digital infrastructure services, and technology-related initiatives. The company is also developing the AIFA platform, which is intended to combine AI computing capacity, fiber-optic network infrastructure, AI education, and AI-related applications.